DesRosier Thomas — SEC insider filings

SEC reporting owner CIK 1435744. 21 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers all 21 filings on record, filed 2021-02-08 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Seres Therapeutics, Inc. (MCRB)See Remarks21—14 legs · 19,821 sh · $23,21652

Insider filings — DesRosier Thomas

FiledFormIssuerReported transactionsSource
2026-11-174Seres Therapeutics, Inc. (MCRB)Option exercise (M): 244 · Sale (S): 103 @ $1.38 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0EDGAR
2026-08-184Seres Therapeutics, Inc. (MCRB)Option exercise (M): 245 · Sale (S): 82 @ $4.55 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 112 (derivative) @ $0EDGAR
2026-07-104Seres Therapeutics, Inc. (MCRB)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2026-05-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 244 · Sale (S): 79 @ $7.53 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0EDGAR
2026-03-064Seres Therapeutics, Inc. (MCRB)Grant/award (A): 22,500 (derivative) @ $0EDGAR
2026-02-184Seres Therapeutics, Inc. (MCRB)Option exercise (M): 244 · Sale (S): 78 @ $8.47 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0EDGAR
2025-11-184Seres Therapeutics, Inc. (MCRB)Option exercise (M): 132 · Option exercise (M): 112 · Sale (S): 76 @ $17.30 · Option exercise (M): 132 (derivative) @ $0 · Option exercise (M): 112 (derivative) @ $0EDGAR
2025-08-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 133 · Option exercise (M): 111 · Sale (S): 76 @ $16.65 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0EDGAR
2025-05-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 133 · Option exercise (M): 111 · Sale (S): 79 @ $7.28 · Option exercise (M): 133 (derivative) @ $0 · Option exercise (M): 111 (derivative) @ $0EDGAR
2025-02-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 2,657 · Option exercise (M): 8,907 · Sale (S): 4,300 @ $0.81 · Option exercise (M): 2,657 (derivative) @ $0 · Option exercise (M): 8,907 (derivative) @ $0EDGAR
2025-02-114Seres Therapeutics, Inc. (MCRB)Grant/award (A): 650,000 (derivative) @ $0EDGAR
2024-11-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 2,656 · Sale (S): 878 @ $0.54 · Option exercise (M): 2,656 (derivative) @ $0EDGAR
2024-10-294Seres Therapeutics, Inc. (MCRB)Option exercise (M): 13,500 @ $0 · Sale (S): 4,259 @ $0.69 · Option exercise (M): 13,500 (derivative) @ $0EDGAR
2024-08-194Seres Therapeutics, Inc. (MCRB)Option exercise (M): 2,656 · Sale (S): 873 @ $0.84 · Option exercise (M): 2,656 (derivative) @ $0EDGAR
2024-05-174Seres Therapeutics, Inc. (MCRB)Option exercise (M): 2,656 · Sale (S): 843 @ $0.94 · Option exercise (M): 2,656 (derivative) @ $0EDGAR
2024-02-164Seres Therapeutics, Inc. (MCRB)Option exercise (M): 10,625 · Sale (S): 3,939 @ $1.08 · Grant/award (A): 213,750 (derivative) @ $0 · Grant/award (A): 287,905 (derivative) @ $0 · Grant/award (A): 35,625 (derivative) @ $0 · Option exercise (M): 10,625 (derivative) @ $0EDGAR
2023-10-314Seres Therapeutics, Inc. (MCRB)Option exercise (M): 13,501 @ $0 · Sale (S): 4,156 @ $1.35 · Grant/award (A): 27,001 (derivative) @ $0 · Option exercise (M): 13,501 (derivative) @ $0EDGAR
2023-02-074Seres Therapeutics, Inc. (MCRB)Grant/award (A): 42,500 (derivative) @ $0 · Grant/award (A): 85,000 (derivative) @ $0EDGAR
2022-07-064Seres Therapeutics, Inc. (MCRB)Grant/award (A): 63,492 @ $3.15EDGAR
2022-02-084Seres Therapeutics, Inc. (MCRB)Grant/award (A): 130,000 (derivative) @ $0EDGAR
2021-02-084Seres Therapeutics, Inc. (MCRB)Grant/award (A): 100,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-10-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1435744 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs